BDX

SEC source: 0001062993-24-014361 · form4.xml · derivative · entry 1

Jones Christopher Ian Montague · CIK 0001292762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,224

Underlying: Common Stock · 124 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-014359 · form4.xml · derivative · entry 1

Byington Carrie L · CIK 0001890265 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,291

Underlying: Common Stock · 124 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-013278 · form4.xml · nonDerivative · entry 1

Spoerel Thomas J · CIK 0001790223 · SVPController & Chief Acct Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,928

F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.

SEC source: 0001062993-24-012343 · form4.xml · nonDerivative · entry 1

Spoerel Thomas J · CIK 0001790223 · SVP,Controller&Chief Acct Off

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,976

SEC source: 0001062993-24-010551 · form4.xml · nonDerivative · entry 3

Goette Roland · CIK 0001708067 · EVP and President EMEA

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,308

F3 · shares: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $237.30 to $237.68. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.

F3 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $237.30 to $237.68. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.

SEC source: 0001062993-24-010551 · form4.xml · nonDerivative · entry 2

Goette Roland · CIK 0001708067 · EVP and President EMEA

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,408

F2 · shares: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $236.29 to $237.28. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.

F2 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $236.29 to $237.28. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.

SEC source: 0001062993-24-010551 · form4.xml · nonDerivative · entry 1

Goette Roland · CIK 0001708067 · EVP and President EMEA

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,808

F1 · shares: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $234.97 to $235.50. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.

F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $234.97 to $235.50. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.

SEC source: 0001062993-24-010311 · form4.xml · nonDerivative · entry 3

Goette Roland · CIK 0001708067 · EVP and President EMEA

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,608

SEC source: 0001062993-24-010311 · form4.xml · nonDerivative · entry 2

Goette Roland · CIK 0001708067 · EVP and President EMEA

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,636

F2 · shares: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $236.74 to $237.73. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.

F2 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $236.74 to $237.73. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.

SEC source: 0001062993-24-010311 · form4.xml · nonDerivative · entry 1

Goette Roland · CIK 0001708067 · EVP and President EMEA

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,208

F1 · shares: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $235.70 to $236.63. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.

F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $235.70 to $236.63. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.

SEC source: 0001062993-24-009402 · form4.xml · derivative · entry 1

Byington Carrie L · CIK 0001890265 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,162

Underlying: Common Stock · 129 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-009400 · form4.xml · derivative · entry 1

Jones Christopher Ian Montague · CIK 0001292762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,954

Underlying: Common Stock · 129 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-009136 · form4.xml · nonDerivative · entry 1

Garrison Michael David · CIK 0001944816 · EVP & President Medical

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,381

SEC source: 0001062993-24-008110 · form4.xml · nonDerivative · entry 1

Neal Shana Carol · CIK 0001735118 · EVP and Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,389

F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.

SEC source: 0001062993-24-006508 · form4.xml · nonDerivative · entry 1

Spoerel Thomas J · CIK 0001790223 · SVP,Controller&Chief Acct Off

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,276

SEC source: 0001062993-24-005404 · form4.xml · nonDerivative · entry 1

Garrison Michael David · CIK 0001944816 · EVP & President Medical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,096

F1 · shares: Represents shares withheld for payment of withholding taxes in connection with vesting of restricted stock units previously reported on Table I.

SEC source: 0001062993-24-005402 · form4.xml · nonDerivative · entry 1

Spoerel Thomas J · CIK 0001790223 · SVP,Controller&Chief Acct Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,558

F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.

SEC source: 0001062993-24-005400 · form4.xml · nonDerivative · entry 1

Ezell Antoine C · CIK 0001826528 · EVP, President NA & CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,320

F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.

SEC source: 0001062993-24-002219 · form4.xml · derivative · entry 1

Jones Christopher Ian Montague · CIK 0001292762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,787

Underlying: Common Stock · 126 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-002215 · form4.xml · derivative · entry 1

Byington Carrie L · CIK 0001890265 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,029

Underlying: Common Stock · 126 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-013502 · form4a.xml · derivative · entry 1

Jones Christopher Ian Montague · CIK 0001292762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,891

Underlying: Common Stock · 230 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis

F3 · shares: This Form 4A amends the Form 4 filed by the reporting person on February 7, 2024 (the "Original Report") to correct the number of shares of BDX common stock allocated to the reporting person under the 1996 Director's Deferral Plan.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F3 · derivative.underlying_shares: This Form 4A amends the Form 4 filed by the reporting person on February 7, 2024 (the "Original Report") to correct the number of shares of BDX common stock allocated to the reporting person under the 1996 Director's Deferral Plan.

F4 · balance_after: Includes rights acquired through dividend reinvestment as of the date of the Original Report.

SEC source: 0001062993-24-001317 · form4.xml · nonDerivative · entry 1

Waldstreicher Joanne · CIK 0001962413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,323

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-001315 · form4.xml · nonDerivative · entry 1

SCOTT BERTRAM L · CIK 0001221780 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,197

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-001313 · form4.xml · nonDerivative · entry 1

RING TIMOTHY M · CIK 0001204666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,890

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-001309 · form4.xml · nonDerivative · entry 1

Jones Christopher Ian Montague · CIK 0001292762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,405

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes righs acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-001307 · form4.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,568

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-001303 · form4.xml · nonDerivative · entry 1

Fraser Claire · CIK 0001382031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,696

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-001301 · form4.xml · nonDerivative · entry 1

ECKERT R ANDREW · CIK 0001210525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,124

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-001299 · form4.xml · nonDerivative · entry 1

Byington Carrie L · CIK 0001890265 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,855

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-001297 · form4.xml · nonDerivative · entry 1

Brown William M · CIK 0001350633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,512

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-001295 · form4.xml · nonDerivative · entry 1

BURZIK CATHERINE M · CIK 0001261141 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,242

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001062993-24-000462 · form4.xml · nonDerivative · entry 1

Shan David · CIK 0001963048 · EVP and Chief ISC Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,693

F1 · shares: Represents shares withheld for payment of withholding taxes in connection with vesting of previously reported restricted stock unit awards.

SEC source: 0001062993-23-022437 · form4.xml · nonDerivative · entry 1

Garrison Michael David · CIK 0001944816 · EVP & President Medical

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,274

SEC source: 0001062993-23-021610 · form4.xml · nonDerivative · entry 1

Byrd Richard · CIK 0001945298 · EVP & President Interventional

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,120

F1 · shares: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $237.23 to $239.40. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.

F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $237.23 to $239.40. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.

SEC source: 0001062993-23-021561 · form4.xml · derivative · entry 5

Spoerel Thomas J · CIK 0001790223 · SVPController & Chief Acct Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,674

Underlying: Common Stock · 2,764 shares

Expires 2033-11-26

F5 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2024.

SEC source: 0001062993-23-021561 · form4.xml · nonDerivative · entry 3

Spoerel Thomas J · CIK 0001790223 · SVPController & Chief Acct Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,594

F3 · shares: Represents shares withheld for payment of withholding taxes in connection with vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units previously reported on Table I.

SEC source: 0001062993-23-021561 · form4.xml · nonDerivative · entry 2

Spoerel Thomas J · CIK 0001790223 · SVPController & Chief Acct Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,959

F2 · shares: Represents shares received upon vesting of performance based equity awards.

SEC source: 0001062993-23-021561 · form4.xml · nonDerivative · entry 1

Spoerel Thomas J · CIK 0001790223 · SVPController & Chief Acct Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,202

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

SEC source: 0001062993-23-021559 · form4.xml · derivative · entry 3

Hickey David · CIK 0001838891 · EVP & President, Life Sciences

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,237

Underlying: Common Stock · 3,024 shares

Expires not disclosed

F3 · derivative.exercise_date: The securities are distributed following termination of the reporting person's employment or on the date or dates specified by the reporting person.

F3 · derivative.expiration_date: The securities are distributed following termination of the reporting person's employment or on the date or dates specified by the reporting person.

SEC source: 0001062993-23-021559 · form4.xml · derivative · entry 2

Hickey David · CIK 0001838891 · EVP & President, Life Sciences

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,213

Underlying: Common Stock · 9,213 shares

Expires 2033-11-26

F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2024.

SEC source: 0001062993-23-021559 · form4.xml · nonDerivative · entry 1

Hickey David · CIK 0001838891 · EVP & President, Life Sciences

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,862

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

SEC source: 0001062993-23-021557 · form4.xml · derivative · entry 4

Byrd Richard · CIK 0001945298 · EVP & President Interventional

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,061

Underlying: Common Stock · 8,061 shares

Expires 2033-11-26

F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2024.

SEC source: 0001062993-23-021557 · form4.xml · nonDerivative · entry 3

Byrd Richard · CIK 0001945298 · EVP & President Interventional

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,276

F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units as previously reported on Table I.

SEC source: 0001062993-23-021557 · form4.xml · nonDerivative · entry 2

Byrd Richard · CIK 0001945298 · EVP & President Interventional

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,785

F2 · shares: Represents shares received upon vesting of performance based equity award.

SEC source: 0001062993-23-021557 · form4.xml · nonDerivative · entry 1

Byrd Richard · CIK 0001945298 · EVP & President Interventional

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,899

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

SEC source: 0001062993-23-021555 · form4.xml · derivative · entry 3

DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,425

Underlying: Common Stock · 18,425 shares

Expires 2033-11-26

F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2024.

SEC source: 0001062993-23-021555 · form4.xml · nonDerivative · entry 2

DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,512

F2 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of previously reported restricted stock unit awards.

SEC source: 0001062993-23-021555 · form4.xml · nonDerivative · entry 1

DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,324

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

SEC source: 0001062993-23-021553 · form4.xml · derivative · entry 4

Garrison Michael David · CIK 0001944816 · EVP & President Medical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,364

Underlying: Common Stock · 10,364 shares

Expires 2033-11-26

F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2024.

SEC source: 0001062993-23-021553 · form4.xml · nonDerivative · entry 3

Garrison Michael David · CIK 0001944816 · EVP & President Medical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,513

F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units as previously reported on Table I.